2000
DOI: 10.1161/01.cir.101.3.318
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Intravenous and Intracoronary Adenosine 5′-Triphosphate as Compared With Adenosine on Coronary Flow and Pressure Dynamics

Abstract: 1) Step up in dosage of ATP and adenosine beyond currently recommended clinical doses resulted in a significant increase in coronary hyperemia; 2) ATP was equivalent to adenosine for both CFR and FFR; and 3) complete coronary occlusion yielded a better hyperemic response than either drug, indicating that maximal hyperemia was not achieved by either pharmacological stimulus.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
44
1
14

Year Published

2001
2001
2013
2013

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 104 publications
(65 citation statements)
references
References 27 publications
6
44
1
14
Order By: Relevance
“…14 -16 In canines, ATP seems to be slightly more potent than adenosine, and it was shown that coronary blood flow could be further augmented with an increase of the dosage. 10 However, in humans, the present data indicate equipotency of ATP and adenosine and do not confirm a longer lasting effect. Increasing the dosages of ATP beyond the recommended dosage of 140 g · kg Ϫ1 · min Ϫ1 did not induce a further decline of the resistance index but induced a marked decline in systemic blood pressure in some patients.…”
Section: Atpcontrasting
confidence: 89%
See 2 more Smart Citations
“…14 -16 In canines, ATP seems to be slightly more potent than adenosine, and it was shown that coronary blood flow could be further augmented with an increase of the dosage. 10 However, in humans, the present data indicate equipotency of ATP and adenosine and do not confirm a longer lasting effect. Increasing the dosages of ATP beyond the recommended dosage of 140 g · kg Ϫ1 · min Ϫ1 did not induce a further decline of the resistance index but induced a marked decline in systemic blood pressure in some patients.…”
Section: Atpcontrasting
confidence: 89%
“…9 Animal experiments also suggest that higher dosages than commonly proposed might be needed to achieve complete hyperemia. 10 In certain patient subsets, the different vasodilators were reported to exert different effects on myocardial resistances. 11 In addition, in animals, maximal hyperemic response, as observed after coronary occlusion, was not achieved by the pharmacological stimuli.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Several previous studies in dogs have compared peak coronary hyperemia after occlusion vs. hyperemia induced by intravenous or intracoronary administration of pharmacological agents. These studies have reported similar results between the two interventions (4,19), as well as higher values during RH (9) or higher values with vasodilators (1,11,33). Differences in agents, concentrations, and route of administration seem to underlie the reported disparity.…”
Section: Rh Vs Ahmentioning
confidence: 60%
“…Comparison of concentrations between human and animal studies is ambiguous, however, because it is suggested that humans are more sensitive to the vasodilator properties of adenosine or have a slower rate of elimination of adenosine than dogs (34). Indeed, intracoronary administration of adenosine at doses used in humans was found to elicit only submaximal hyperemia in dogs (9). Although the use of milligram doses of adenosine in the clinic has been advocated (14), our data suggest that application of such high adenosine concentrations might increase the discrepancy between pharmacologically induced dilation vs. ischemia-induced hyperemia.…”
Section: Rh Vs Ahmentioning
confidence: 99%